BYPLF (Bodycote) Accounts Payable & Accrued Expense: $245.8 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BYPLF Bodycote PLC BYPLF
74 GF Score
Price $12.30
GF Value $9.05
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Bodycote Accounts Payable & Accrued Expense?

Bodycote BYPLF 74 Accounts Payable & Accrued Expense is $245.8 Mil as of Jun. 2026. GuruFocus rates BYPLF with a GF Score™ of 74/100 and a GF Value™ of $9.05 (Significantly Overvalued). The stock has 7 warning signs investors should review.

Bodycote's quarterly accounts payable & accrued expense increased from Jun. 2025 ($204.3 Mil) to Dec. 2025 ($210.5 Mil) and increased from Dec. 2025 ($210.5 Mil) to Jun. 2026 ($245.8 Mil).

Bodycote's annual accounts payable & accrued expense increased from Dec. 2023 ($125.6 Mil) to Dec. 2024 ($144.4 Mil) but then declined from Dec. 2024 ($144.4 Mil) to Dec. 2025 ($134.9 Mil).


Bodycote Accounts Payable & Accrued Expense Historical Data

* Premium members only.

The historical data trend for Bodycote's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bodycote Accounts Payable & Accrued Expense Chart

Bodycote Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable & Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 155.49 123.78 125.57 144.40 134.91

Bodycote Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Accounts Payable & Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 207.94 224.05 204.32 210.50 245.81
BYPLF
74GF Score
Bodycote PLC BYPLF
Accounts Payable & Accrued Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bodycote Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

What does a Accounts Payable & Accrued Expense of $245.8 Mil mean?
Bodycote (BYPLF) has a Accounts Payable & Accrued Expense of $245.8 Mil as of Jun. 2026. Accounts payable and accrued expenses are amounts a company expects to pay to suppliers and others. View historical data on Bodycote and its competitors.
Is Bodycote's Accounts Payable & Accrued Expense too high?
Bodycote's current Accounts Payable & Accrued Expense is $245.8 Mil. Overall, Bodycote has a GF Score™ of 74/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Bodycote's Accounts Payable & Accrued Expense compare to GEV and ETN?
Bodycote's Accounts Payable & Accrued Expense of $245.8 Mil can be compared against companies in the Industrial Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable & Accrued Expense for an Industrial Products company?
A good Accounts Payable & Accrued Expense depends on the Industrial Products industry context. However, Accounts Payable & Accrued Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable & Accrued Expense mean?
A high Accounts Payable & Accrued Expense can signal that a stock is expensive relative to its fundamentals. Accounts payable and accrued expenses are amounts a company expects to pay to suppliers and others. View historical data on Bodycote and its competitors. Bodycote's current Accounts Payable & Accrued Expense is $245.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bodycote stock overvalued right now?
Based on GuruFocus' analysis, Bodycote (BYPLF) is currently considered Significantly Overvalued. The stock's GF Value™ is $9.05, compared to a current price of $12.30 — trading 35.9% above its estimated fair value. The current Accounts Payable & Accrued Expense is $245.8 Mil. Bodycote's overall GF Score™ is 74/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable & Accrued Expense calculated?
Accounts Payable & Accrued Expense is calculated from a company's financial statements. For Bodycote (BYPLF), the current Accounts Payable & Accrued Expense is $245.8 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bodycote (BYPLF) Overvalued in 2026?

Based on GuruFocus' analysis, Bodycote stock appears to be overvalued. The current stock price of $12.30 is trading 35.9% above its estimated GF Value™ of $9.05. GuruFocus considers Bodycote to be Significantly Overvalued.

Key valuation signals for BYPLF:

  • Accounts Payable & Accrued Expense: $245.8 Mil
  • GF Value™: $9.05 vs. price of $12.30 (35.9% above fair value)
  • GF Score™: 74/100 with 7 warning signs

No single metric tells the full story. See the BYPLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bodycote Business Description

Other Exchanges BOYl:UKBOY:UK21T:Germany
Address Tytherington Business Park, Springwood Court, Springwood Close, Macclesfield, Cheshire, GBR, SK10 2XF
Bodycote PLC provides thermal processing services including heat treatment, metal joining, surface coating technologies, and hot isostatic pressing. It organizes its plants into three divisions: Specialist Technologies, Precision Heat Treatment, and Non-core. It generatesmajority of its revenue from Specialist Technologies segment This division includes the Group's Hot Isostatic Pressing (HIP) business; its Speciality Stainless Steel Processes (S3P) business and its Surface Technology business. It has a geographical presence in the USA, France, Germany, the UK, Sweden, Netherlands.
74GF Score

Get the complete analysis for BYPLF

Accounts Payable & Accrued Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$12.30
Price
$9.05
GF Value